Your browser doesn't support javascript.
loading
The Association Between Mean Corpuscular Hemoglobin Concentration and Prognosis in Patients with Acute Pulmonary Embolism: A Retrospective Cohort Study.
Ruan, Zhishen; Li, Dan; Hu, Yuanlong; Qiu, Zhanjun; Chen, Xianhai.
Afiliación
  • Ruan Z; The First Clinical College, 74738Shandong Chinese Medical University, Ji Nan, People's Republic of China.
  • Li D; The First Clinical College, 74738Shandong Chinese Medical University, Ji Nan, People's Republic of China.
  • Hu Y; The First Clinical College, 74738Shandong Chinese Medical University, Ji Nan, People's Republic of China.
  • Qiu Z; Department of Pulmonary and Critical Care Medicine, 159393The First Affiliated Hospital of Shandong Chinese Medical University, Ji Nan, People's Republic of China.
  • Chen X; Department of Pulmonary and Critical Care Medicine, 159393The First Affiliated Hospital of Shandong Chinese Medical University, Ji Nan, People's Republic of China.
Clin Appl Thromb Hemost ; 28: 10760296221103867, 2022.
Article en En | MEDLINE | ID: mdl-35642292
ABSTRACT

INTRODUCTION:

Acute pulmonary embolism (APE) is a typical cardiovascular emergency worldwide. Mean hemoglobin concentration (MCHC) is a standard indicator of anemia. Studies on the association between MCHC and APE are scarce. We aimed to investigate the relationship between MCHC and APE.

METHODS:

Clinical data were extracted from the Medical Information Bank for Intensive Care (MIMIC)-III. Adult (≥18 years) patients with APE admitted for the first time were included in this study. An analysis was conducted to evaluate the association between MCHC and the prognosis of patients by the Cox regression analysis, generalized additives models and Kaplan-Meier survival curves. The primary outcome was 30-day mortality, and the secondary outcomes were 1-year and 3-year mortality.

RESULTS:

A total of 813 patients who met the selection criteria were enrolled, of whom 130 (16.0%) died within 30 days of admission. Univariate Cox regression indicated that MCHC was significantly associated with mortality (30-day HR = 0.74, 95% CI = 0.66-0.82, P < 0.001; 1-year HR = 0.80, 95% CI = 0.74-0.86, P < 0.001; 3-year HR = 0.82, 95% CI = 0.77-0.88, P < 0.001). MCHC remains stable after adjusting multiple models. Kaplan-Meier survival curves showed that patients with lower MCHC had a poorer 30-day prognosis.

CONCLUSIONS:

Lower MCHC is an independent risk factor for increased mortality in patients with APE. As an inexpensive biomarker, MCHC should receive more attention.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Embolia Pulmonar / Índices de Eritrocitos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Clin Appl Thromb Hemost Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Embolia Pulmonar / Índices de Eritrocitos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Clin Appl Thromb Hemost Asunto de la revista: ANGIOLOGIA Año: 2022 Tipo del documento: Article
...